Radiotherapy for HER 2 Positive Brain Metastases: Urgent Need for a Paradigm Shift

SIMPLE SUMMARY: Brain metastases (BMs) are common among patients with advanced HER2 breast cancer. The recent introduction of systemic therapy with central nervous system activity as well as the wider use of brain stereotactic radiotherapy (SRT) are contributing to improving the outcomes for these p...

Descripción completa

Detalles Bibliográficos
Autores principales: Ippolito, Edy, Silipigni, Sonia, Matteucci, Paolo, Greco, Carlo, Carrafiello, Sofia, Palumbo, Vincenzo, Tacconi, Claudia, Talocco, Claudia, Fiore, Michele, D’Angelillo, Rolando Maria, Ramella, Sara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8946529/
https://www.ncbi.nlm.nih.gov/pubmed/35326665
http://dx.doi.org/10.3390/cancers14061514

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8946529/
https://www.ncbi.nlm.nih.gov/pubmed/35326665
http://dx.doi.org/10.3390/cancers14061514

Ejemplares similares